Insurance Coverage for Substance Use Treatment, What New York Plans Must Cover

March 6, 2024
•
Category

Most people who need addiction treatment never receive it, and cost is one of the reasons they name most often. In the 2025 National Survey on Drug Use and Health, 47.2 million people aged 12 or older needed substance use treatment, and 84 percent of them received none. Among adults who went without care, 30.4 percent said they did not have enough health insurance coverage to pay for treatment.

That belief is often wrong. Insurance coverage for substance use treatment is broader than most people assume, and in New York it is protected by some of the strongest state rules in the country. Federal law requires most plans to cover addiction treatment as an essential health benefit and to cover it on terms comparable to medical care. New York law goes further and limits what an insurer may demand before an inpatient admission at a licensed facility.

This guide explains what your plan is required to cover, how coverage differs across levels of care, what the New York rules mean in practice, and how to confirm your benefits before you commit to anything. If you would rather have someone check your plan for you, our intake team verifies insurance as part of the admissions process, and you can reach them at 888-227-4641.

What the current national data shows

The figures below come from the 2025 National Survey on Drug Use and Health, released by SAMHSA on July 27, 2026.

  • 44.6 million people aged 12 or older, or 15.3 percent of the population, met the criteria for a substance use disorder in the past year, down from 16.8 percent in 2024.
  • Of the 47.2 million people classified as needing treatment, 16.0 percent received it and 84.0 percent, roughly 39.6 million people, did not.
  • Only 15.7 percent of people with a past year opioid use disorder received medication for it, and only 2.6 percent of those with an alcohol use disorder received medication for it.
  • 22.3 million adults considered themselves to be in recovery from a drug or alcohol problem.

The reasons people gave for going without care are worth reading closely, because several are solvable. Among adults who had a substance use disorder, did not receive treatment, and recognized a need for it, 82.5 percent believed they should be able to manage on their own, 68.4 percent were not ready to stop, 34.9 percent feared consequences such as losing a job, a home, or custody of their children, and 30.4 percent said they did not have enough health insurance coverage to pay for treatment. Respondents could select more than one reason, so the figures total more than one hundred percent.

The medication numbers point at the same problem from a different angle. In most cases the benefit exists and goes unclaimed.

What federal law requires, and what it does not

Essential health benefits

Plans sold in the individual and small group markets, including plans sold through the Health Insurance Marketplace, must cover substance use disorder services as an essential health benefit. That includes behavioral health treatment, counseling, medication-assisted treatment, and inpatient services. An insurer cannot refuse to cover treatment for a substance use disorder when it is a basic benefit of the plan, regardless of prior diagnosis or prior treatment.

Large group plans and self-funded employer plans are a different matter. They are not bound by the essential health benefit rules, though they are bound by federal parity law. This is the distinction most people miss when they read that addiction treatment is covered by law.

The Mental Health Parity and Addiction Equity Act

The federal parity law of 2008 requires health insurers and group health plans to cover mental health and substance use disorder treatment on terms comparable to medical and surgical care. A plan may not impose financial requirements or treatment limitations on addiction treatment that are more restrictive than those it applies to medical benefits. The Affordable Care Act extended parity protections to individual policies and to Medicaid expansion coverage.

What the federal floor does not do is standardize the details. Deductibles, coinsurance, network rules, and documentation requirements vary widely between plans, and two people with the same diagnosis at the same facility can owe very different amounts. That is why verification matters more than any general rule.

One current caveat on parity

The parity statute is settled law and remains fully in effect. The regulations interpreting it are not settled. Federal agencies issued a new parity rule in September 2024, then announced on May 15, 2025 that they would not enforce the provisions that were new relative to the earlier 2013 rule. That non-enforcement policy runs until a final decision in the pending industry lawsuit plus an additional 18 months, which is why it has no fixed end date. In a court filing on March 30, 2026, the agencies said they would not defend the 2024 rule and intend to propose replacement regulations, with a stated target of no later than December 31, 2026.

For a patient the practical takeaway is narrow. Parity protection has not gone away, the 2013 regulations still stand, the statutory requirement that plans document their treatment limitations still stands, and federal regulators have said parity enforcement remains a priority. What is in flux is the newer layer of technical compliance rules that plans must follow. If a plan tells you addiction treatment is simply not covered, or applies limits it does not apply to medical care, that is still worth challenging.

‍

The New York rules that matter most

New York gives residents protections that go beyond the federal floor. They apply to substance use treatment at facilities licensed or otherwise authorized by the New York State Office of Addiction Services and Supports, known as OASAS, that participate in your insurer network. Arms Acres is an OASAS-licensed facility.

The rules come from Chapters 69 and 71 of the Laws of 2016, as modified by Chapter 57 of the Laws of 2019, and are set out in OASAS implementation guidance last revised in December 2025. The current version, effective for policies issued or renewed on or after January 1, 2020, works as follows.

  • No prior authorization. Your insurer may not require prior authorization for medically necessary inpatient, residential, or detox treatment at an in-network OASAS-certified facility, nor for in-network outpatient clinic, outpatient rehabilitation, or opioid treatment program services.
  • No utilization review for the first 28 days. For in-network inpatient or residential care, the insurer may not conduct concurrent utilization review during the first 28 calendar days from admission, provided the facility notifies the insurer of the admission and the initial treatment plan within two business days, assesses the patient clinically each day, and consults with the insurer at or before the 14th day.
  • The same shield applies to outpatient care. For in-network outpatient treatment, the protection runs for the first four weeks of continuous treatment, not to exceed 28 visits, on the same notification terms.
  • A required level of care tool. New York insurers and providers must both use the Level of Care for Alcohol and Drug Treatment Referral, known as LOCADTR 3.0, to determine the appropriate setting. A medical necessity denial is supposed to rest on that tool rather than on the insurer's own internal standard, so both sides of the phone are working from the same criteria.
  • No recouping a denial from you. Where an insurer denies payment after a retrospective review, the provider may not seek that money from the patient.
  • Telehealth is reimbursable. Insurers regulated by New York must reimburse substance use treatment delivered by telehealth, including audio only.

Two limits are worth reading twice. These protections attach to in-network providers, so out of network care can still face prior authorization and concurrent review. And they bind insurers regulated by New York State, which means a fully insured New York plan is covered while a self-funded employer plan generally is not, even if the employer is based in New York.

In plain terms, an eligible person in New York should not be sitting in withdrawal waiting on an insurer to approve a bed. That is the difference between reading about treatment and starting it. The medically supervised detox program and the adult rehabilitation program both operate under OASAS licensure at the Carmel campus.

Types of coverage, and why the difference matters

Commercial and employer plans

Commercial and employer-sponsored plans cover addiction treatment but differ sharply in deductible, coinsurance, network breadth, and documentation burden. The distinction that matters most is whether the plan is fully insured and regulated by New York State, in which case the state protections above apply, or self-funded by the employer, in which case federal parity rules apply but New York insurance law generally does not. Your benefits administrator can tell you which one you have, and it is the first question worth asking.

Medicaid

New York Medicaid covers the full continuum of OASAS-certified care, and Medicaid managed care plans are barred from requiring prior authorization for ambulatory substance use services. Because Medicaid coverage works differently enough to warrant its own explanation, it is covered in detail.

How coverage works at each level of care

Addiction treatment is not one service. Plans price and authorize each level separately, so knowing which level you are asking about makes a benefit check far more accurate.

Medically supervised withdrawal, or detox

The most acute level, delivered inpatient with medical monitoring. Because it is medically necessary and time-sensitive, it is generally the best covered level of care and, in New York, the level protected from prior authorization at in-network OASAS facilities. See our detox program.

Inpatient rehabilitation

Residential treatment following stabilization, combining clinical therapy, group work, and discharge planning. Plans typically authorize an initial length of stay and review continued need after the protected period. See our adult rehabilitation program and the inpatient overview.

Outpatient treatment

Scheduled clinical care while living at home, usually the longest phase of treatment and the one most people underestimate when budgeting. Arms Acres operates three clinics, and coverage is checked per clinic because network status can differ. See outpatient services, Carmel outpatient, Bronx outpatient, and Queens outpatient.

Medication-assisted treatment

Medications for Addiction Treatment (MAT) can be a helpful component of substance-use treatment, particularly for individuals with a physical dependency on substances such as alcohol, nicotine, and opioids. These medications, used in combination with counseling and other treatment services, can aid in reducing cravings, managing withdrawal symptoms, and supporting long-term recovery.

Insurance coverage for MAT varies depending on the specific insurance plan. However, many insurance providers recognize the effectiveness of these medications and offer coverage for them. The 2025 federal data shows how badly underused this is, with only 15.7 percent of people with opioid use disorder and 2.6 percent of those with alcohol use disorder receiving medication for it. See our medication-assisted therapy program.

Psychiatric and co-occurring care

Many people entering treatment have a co-occurring mental health condition, and that care is billed alongside addiction treatment. Our psychiatric services are part of the clinical program rather than a separate referral.

Recovery support after discharge

Coverage for post-discharge support varies most of all, and is worth asking about before you need it. See recovery coach services and our full services overview.

What actually determines your cost

Outside the protections described above, two mechanisms decide what a plan pays.

Prior authorization and utilization review

Prior authorization means the plan must approve treatment before it begins. Utilization review means the plan assesses whether continued treatment remains medically necessary, often requesting progress reports from the treating program. Both are common across the industry and both vary by plan. In New York, both are restricted for in-network OASAS-certified care during the protected periods described above, which is precisely why network status and plan type are the two questions worth settling first.

Day and visit limits

Plans may cap the number of covered inpatient days or outpatient visits. Where parity applies, those caps cannot be more restrictive than the ones the plan applies to comparable medical care, which makes an unusually tight limit worth questioning rather than accepting.

How to verify your coverage before you commit

You can do this yourself, or you can let intake do it. Either way, these are the questions that determine what you will actually pay.

  • Is Arms Acres in network for my specific plan, not just my insurer? Network status is set at the plan level.
  • Is my plan fully insured and regulated by New York State, or is it a self-funded employer plan?
  • What is my remaining deductible this year, and does inpatient treatment apply to it?
  • What is my coinsurance or per day cost share for inpatient substance use treatment, and what is my out-of-pocket maximum?
  • Is prior authorization required, and if my plan is regulated by New York, does the OASAS restriction on prior authorization apply to me?
  • What are my outpatient benefits after discharge, including visit limits and cost share?
  • Is medication-assisted treatment covered, and is any specific medication subject to prior authorization?

Arms Acres intake coordinators verify insurance as a standard part of the admissions process, alongside the clinical intake questions and scheduling. Bed availability changes hour to hour, so an early call is worth more than a perfect plan. For inpatient intake, call 888-227-4641. For outpatient, contact the clinic directly, in the Bronx at 718-653-1537, in Carmel at 845-704-6133, or in Queens at 718-520-1513. View our admissions overview.

If your claim is denied

A denial is not the end of the process, and denials in this category are overturned often enough that the appeal is worth filing.

  • Ask for the denial reason in writing, including the specific clinical criteria applied.
  • Ask whether the reviewer used LOCADTR 3.0. For plans regulated by New York, a medical necessity denial for covered substance use treatment is supposed to rest on that tool.
  • Use the plan internal appeal first, and ask about an expedited appeal if care is ongoing or imminent.
  • Escalate to the New York State Department of Financial Services, which operates an external appeal and complaint process for insured plans.
  • Ask the facility to help. Clinical documentation from the treating program is usually what turns an appeal.

Parity gives you a second line of argument. If your plan approves comparable medical admissions with less documentation, or applies review to addiction treatment that it does not apply elsewhere, that disparity is itself grounds for challenge.

Frequently asked questions

Does insurance cover rehab in New York?

In most cases, yes. Plans in the individual and small group markets must cover substance use disorder treatment as an essential health benefit, larger plans are bound by federal parity rules, and New York adds protections for treatment at OASAS-licensed facilities that participate in your insurer network. What varies is your cost share, not whether the benefit exists.

Do I need prior authorization for detox in New York?

For an inpatient substance use disorder admission at an in-network OASAS-certified facility, New York law prohibits insurers from requiring prior authorization, and bars concurrent review during the first 28 calendar days when the facility notifies the insurer within two business days and meets the daily assessment and consultation requirements. Self-funded employer plans are generally not subject to these state rules.

What will I actually pay?

Your copayment, coinsurance, and deductible as set by your policy. If an insurer denies payment after a retrospective review of covered substance use treatment, New York rules bar the provider from seeking that amount from you.

How long will insurance cover treatment?

Length of stay is a clinical decision, and continued coverage generally depends on documented medical necessity. In New York, insurers may not conduct concurrent review during the first 28 days of a protected inpatient admission, which gives the clinical team room to plan rather than negotiate.

Will my employer find out?

Fear of consequences at work, at home, or with custody was named by 34.9 percent of adults who needed treatment and did not get it. Patient information is protected, and the federal rules governing substance use disorder records are stricter than general medical privacy rules. See the confidentiality policy at https://www.armsacres.com/patient-confidentiality-privacy.

What if I have no insurance?

Call intake at 888-227-4641. OASAS states that funded treatment providers cannot turn a person away for an inability to pay, and intake staff can talk through the options that apply to your situation and current availability.

Start with a benefit check, not a guess

Nearly 40 million people who needed treatment last year did not receive it, and roughly three in ten of the adults among them pointed at insurance. Very often the coverage was there and the clarity was not.

Arms Acres is licensed by the New York State Office of Addiction Services and Supports and accredited by the Joint Commission. The campus is at 75 Seminary Hill Road in Carmel, with outpatient clinics in Carmel, the Bronx, and Queens. Call 888-227-4641 for inpatient intake, or use the contact form at https://www.armsacres.com/contact and the team will verify your benefits and tell you where you stand.

Sources

  • SAMHSA, Key Substance Use and Mental Health Indicators in the United States, results from the 2025 National Survey on Drug Use and Health, released July 27, 2026, at https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health/national-releases/2025.
  • HealthCare.gov, mental health and substance abuse coverage, at https://www.healthcare.gov/coverage/mental-health-substance-abuse-coverage/.
  • U.S. Department of Labor, statement regarding enforcement of the final rule on requirements related to the Mental Health Parity and Addiction Equity Act, May 15, 2025, at https://www.dol.gov/agencies/ebsa/laws-and-regulations/laws/mental-health-parity/statement-regarding-enforcement-of-the-final-rule-on-requirements-related-to-mhpaea.
  • NYS Office of Addiction Services and Supports, Guidance for Implementation and Utilization Review for Addiction Services, revised December 2025, at https://oasas.ny.gov/implementation-and-utilization-review-guidance.
  • NYS Office of Addiction Services and Supports, Paying for Treatment, at https://oasas.ny.gov/treatment/paying-treatment.
  • NYS Department of Financial Services, external appeal and complaint process, at https://www.dfs.ny.gov/complaints/file_external_appeal.

For exclusive news
and resources

Subscribe
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.